Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors.

S Creedican; Robinson CM; K Mnich; Islam MN; Eva Szegezdi; R Clifford; Janusz Krawczyk; Patterson JB; FitzGerald SP; M Summers; C Richardson; K Martin; Adrienne Gorman; A Samali

doi:10.1111/jcmm.17479

Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors.

S Creedican, Robinson CM, K Mnich, Islam MN, Eva Szegezdi, R Clifford, Janusz Krawczyk, Patterson JB, FitzGerald SP, M Summers, C Richardson, K Martin, Adrienne Gorman, A Samali

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Pages (from-to)	4629-4633
Number of pages	5
Journal	Journal of Cellular and Molecular Medicine
Volume	26
Issue number	16
DOIs	https://doi.org/10.1111/jcmm.17479
Publication status	Published - Aug 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jcmm.17479

Cite this

Creedican, S., CM, R., Mnich, K., MN, I., Szegezdi, E., Clifford, R., Krawczyk, J., JB, P., SP, F., Summers, M., Richardson, C., Martin, K., Gorman, A., & Samali, A. (2022). Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors. Journal of Cellular and Molecular Medicine, 26(16), 4629-4633. https://doi.org/10.1111/jcmm.17479

@article{0fc17112685543bb8ae28a1ea790fa34,

title = "Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors.",

author = "S Creedican and Robinson CM and K Mnich and Islam MN and Eva Szegezdi and R Clifford and Janusz Krawczyk and Patterson JB and FitzGerald SP and M Summers and C Richardson and K Martin and Adrienne Gorman and A Samali",

year = "2022",

month = aug,

doi = "10.1111/jcmm.17479",

language = "Undefined/Unknown",

volume = "26",

pages = "4629--4633",

journal = "Journal of Cellular and Molecular Medicine",

issn = "1582-1838",

number = "16",

}

Creedican, S, CM, R, Mnich, K, MN, I, Szegezdi, E, Clifford, R, Krawczyk, J, JB, P, SP, F, Summers, M, Richardson, C, Martin, K, Gorman, A & Samali, A 2022, 'Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors.', Journal of Cellular and Molecular Medicine, vol. 26, no. 16, pp. 4629-4633. https://doi.org/10.1111/jcmm.17479

TY - JOUR

T1 - Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors.

AU - Creedican, S

AU - CM, Robinson

AU - Mnich, K

AU - MN, Islam

AU - Szegezdi, Eva

AU - Clifford, R

AU - Krawczyk, Janusz

AU - JB, Patterson

AU - SP, FitzGerald

AU - Summers, M

AU - Richardson, C

AU - Martin, K

AU - Gorman, Adrienne

AU - Samali, A

PY - 2022/8

Y1 - 2022/8

UR - https://europepmc.org/articles/PMC9357667

U2 - 10.1111/jcmm.17479

DO - 10.1111/jcmm.17479

M3 - Article

C2 - 35822520

SN - 1582-1838

VL - 26

SP - 4629

EP - 4633

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

IS - 16

ER -

Inhibition of IRE1α RNase activity sensitizes patient-derived acute myeloid leukaemia cells to proteasome inhibitors.

UN SDGs

Access to Document

Other files and links

Cite this